Genomics
基因组学
基本信息
- 批准号:7635790
- 负责人:
- 金额:$ 24.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-06-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAgeAmino AcidsAntiviral AgentsApoptosisAreaBioinformaticsBiological AssayBiologyCD4 Positive T LymphocytesCodeDataDetectionDevelopmentDiseaseDisease ProgressionEffectivenessEquipmentEvolutionFunctional RNAGene ExpressionGenesGeneticGenetic PolymorphismGenetic Predisposition to DiseaseGenomeGenomicsHIVHIV encephalitisHumanInfectionLaboratoriesMethamphetamineMicroRNAsMicroarray AnalysisMolecular ProfilingNucleic AcidsNumbersOpportunistic InfectionsPathogenesisPathway interactionsPharmacotherapyPolymerase Chain ReactionProcessResearchResearch PersonnelReverse Transcriptase Polymerase Chain ReactionRitonavirSamplingScreening procedureSingle Nucleotide PolymorphismSystemTechniquesTechnologyTimeTrainingTranslatingViralcostcost effectivedesigndrug developmentdrug metabolismmammalian genomemicrosystemspathogenresearch studytherapeutic target
项目摘要
In this current age of genome biology, the primary objective of the Genomics Core is to accelerate the
study of HIV and opportunistic infections associated with AIDS by providing researchers with access to
genomic technologies. Examining host genetics following pathogen infection can identify new targets and
pathways for drug development, reveal the genetic mechanisms of disease pathogenesis, determine
predictive gene expression profiles that can guide treatment options, and identify single nucleotide
polymorphisms (SNPs) associated with disease that can be used to judge the effectiveness of different
antiviral drug therapies. To facilitate such research, the specific aims of the Genomics Core are as follows:
(1) to provide researchers with a cost-effective mechanism to analyze mammalian gene expression at the
whole genome level using microarray technology, (2) to enable the more precise quantification of both
coding and non-coding gene expression using real-time quantitative RT-PCR (qRT-PCR), (3) to screen
large numbers of samples for specific SNPs, and (4) to offer expertise and training in bioinformatics
applications required to process and interpret the data generated by genomic technologies. The Genomics
Core is currently outfitted with a suite of laboratory equipment to meet these aims (2 x ABI Prism 7700
Sequence Detection Systems, a Bio-Rad iCycler, an Affymetrix Fluidics Station 400 and a Sun
Microsystems Sunfire 250 Enterprise server). Staff at the core are highly trained and skilled in areas of
nucleic acid isolation, purification and quantification, and primer design, gene expression assays and
bioinformatic analysis. In summary, the contribution of the Genomics Core to HIV- and AIDS-related
research is best reflected by the numerous projects supported by the core, among which include the first
assessment of HIV-stimulated gene expression in CD4 T cells, identification of pathways resulting in HIV
induced apoptosis, the effects of methamphetamine use on HIV encephalitis, and identification of the
amino acid polymorphisms that contribute to ritonavir hypersusceptibility. This proposal will allow the
Genomics Core to continue bridging the gap between HIV-related research and genomic technologies in an
economical manner. This will allow HIV research to benefit from the very latest developments in genome
biology, which will ultimately translate into a better understanding of disease pathogenesis and the
evolution of better therapies.
在当前的基因组生物学时代,基因组学核心的主要目标是加速基因组学的发展。
研究艾滋病毒和与艾滋病有关的机会性感染,
基因组技术。病原体感染后检查宿主遗传学可以识别新的靶标,
药物开发的途径,揭示疾病发病的遗传机制,确定
预测基因表达谱,可以指导治疗方案,并确定单核苷酸
与疾病相关的多态性(SNP),可用于判断不同药物的有效性。
抗病毒药物治疗。为了促进这种研究,基因组学核心的具体目标如下:
(1)为研究人员提供了一个具有成本效益的机制,以分析哺乳动物的基因表达,
使用微阵列技术的全基因组水平,(2)能够更精确地定量
使用实时定量RT-PCR(qRT-PCR)的编码和非编码基因表达,(3)筛选
大量特定SNP的样本,以及(4)提供生物信息学方面的专业知识和培训
处理和解释基因组技术产生的数据所需的应用程序。基因组学
核心目前配备了一套实验室设备,以满足这些目标(2 x ABI Prism 7700
序列检测系统、Bio-Rad iCycler、Affyphidics Fluidics Station 400和Sun
Microsystems Sunfire 250 Enterprise服务器)。核心工作人员在下列领域受过高度培训并掌握技能:
核酸分离、纯化和定量,以及引物设计、基因表达测定和
生物信息学分析总之,基因组学核心对艾滋病毒和艾滋病相关领域的贡献
核心支助的许多项目最能反映研究工作,其中包括第一个
评估CD 4 T细胞中HIV刺激的基因表达,鉴定导致HIV
诱导的细胞凋亡,甲基苯丙胺使用对HIV脑炎的影响,
导致利托那韦过敏的氨基酸多态性。该提案将允许
基因组学核心将继续弥合艾滋病毒相关研究与基因组技术之间的差距,
经济的方式。这将使艾滋病毒研究受益于基因组的最新发展,
生物学,这最终将转化为对疾病发病机制和治疗方法的更好理解
更好的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPHER H WOELK其他文献
CHRISTOPHER H WOELK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPHER H WOELK', 18)}}的其他基金
Synthetic Molecular Sensors to Target Latently Infected Cells for HIV Eradication
合成分子传感器瞄准潜在感染细胞以根除艾滋病毒
- 批准号:
8657164 - 财政年份:2013
- 资助金额:
$ 24.5万 - 项目类别:
Synthetic Molecular Sensors to Target Latently Infected Cells for HIV Eradication
合成分子传感器瞄准潜在感染细胞以根除艾滋病毒
- 批准号:
8463060 - 财政年份:2013
- 资助金额:
$ 24.5万 - 项目类别:
Synthetic Molecular Sensors to Target Latently Infected Cells for HIV Eradication
合成分子传感器瞄准潜在感染细胞以根除艾滋病毒
- 批准号:
8607892 - 财政年份:2013
- 资助金额:
$ 24.5万 - 项目类别:
Gene expression biomarkers of immune recovery in HIV infected patients
HIV感染者免疫恢复的基因表达生物标志物
- 批准号:
7996540 - 财政年份:2009
- 资助金额:
$ 24.5万 - 项目类别:
Gene expression biomarkers of immune recovery in HIV infected patients
HIV感染者免疫恢复的基因表达生物标志物
- 批准号:
8196805 - 财政年份:2009
- 资助金额:
$ 24.5万 - 项目类别:
INTERFERON STIMULATED GENES WITH ANTIVIRAL PROPERTIES TO HIV-1
干扰素刺激基因具有抗 HIV-1 病毒特性
- 批准号:
8166821 - 财政年份:2009
- 资助金额:
$ 24.5万 - 项目类别:
Gene expression biomarkers of immune recovery in HIV infected patients
HIV感染者免疫恢复的基因表达生物标志物
- 批准号:
7840606 - 财政年份:2009
- 资助金额:
$ 24.5万 - 项目类别:
INTERFERON STIMULATED GENES WITH ANTIVIRAL PROPERTIES TO HIV-1
干扰素刺激基因具有抗 HIV-1 病毒特性
- 批准号:
7950962 - 财政年份:2008
- 资助金额:
$ 24.5万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 24.5万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 24.5万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 24.5万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 24.5万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 24.5万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 24.5万 - 项目类别:
Studies on cofactors for development of acquired immunodeficiency syndrome in feline immunodeficiency virus infection.
猫免疫缺陷病毒感染后获得性免疫缺陷综合征发生的辅助因子研究。
- 批准号:
03660315 - 财政年份:1991
- 资助金额:
$ 24.5万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 24.5万 - 项目类别:














{{item.name}}会员




